Roche Holding AG (XSWX:ROP) Other Current Payables: CHF1,305 Mil (As of Dec. 2025)


XSWX:ROP Roche Holding AG XSWX:ROP
78 GF Score
Price CHF332.80
GF Value CHF264.67
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Roche Holding AG Other Current Payables?

Roche Holding AG XSWX:ROP -1.77% 78 Other Current Payables is CHF1,305 Mil as of Dec. 2025. GuruFocus rates XSWX:ROP with a GF Score™ of 78/100 and a GF Value™ of CHF264.67 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Roche Holding AG's Other Current Payables for the quarter that ended in Dec. 2025 was CHF1,305 Mil.

Roche Holding AG's quarterly Other Current Payables declined from Dec. 2024 (CHF733 Mil) to Jun. 2025 (CHF0 Mil) but then increased from Jun. 2025 (CHF0 Mil) to Dec. 2025 (CHF1,305 Mil).

Roche Holding AG's annual Other Current Payables increased from Dec. 2023 (CHF460 Mil) to Dec. 2024 (CHF733 Mil) and increased from Dec. 2024 (CHF733 Mil) to Dec. 2025 (CHF1,305 Mil).

Roche Holding AG Other Current Payables Related Terms

Roche Holding AG Other Current Payables Historical Data

* Premium members only.

The historical data trend for Roche Holding AG's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roche Holding AG Other Current Payables Chart

Roche Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 416.00 432.00 460.00 733.00 1,305.00

Roche Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 460.00 0.00 733.00 0.00 1,305.00
XSWX:ROP
78GF Score
Roche Holding AG XSWX:ROP
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Roche Holding AG Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of CHF1,305 Mil mean?
Roche Holding AG (XSWX:ROP) has a Other Current Payables of CHF1,305 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Roche Holding AG and its competitors.
Is Roche Holding AG's Other Current Payables too high?
Roche Holding AG's current Other Current Payables is CHF1,305 Mil. Overall, Roche Holding AG has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Roche Holding AG's Other Current Payables compare to LLY and JNJ?
Roche Holding AG's Other Current Payables of CHF1,305 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Roche Holding AG and its competitors. Roche Holding AG's current Other Current Payables is CHF1,305 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roche Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Roche Holding AG (XSWX:ROP) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF264.67, compared to a current price of CHF332.80 — trading 25.7% above its estimated fair value. The current Other Current Payables is CHF1,305 Mil. Roche Holding AG's overall GF Score™ is 78/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Roche Holding AG (XSWX:ROP), the current Other Current Payables is CHF1,305 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Roche Holding AG (XSWX:ROP) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of CHF332.80 is trading 25.7% above its estimated GF Value™ of CHF264.67. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for XSWX:ROP:

  • Other Current Payables: CHF1,305 Mil
  • GF Value™: CHF264.67 vs. price of CHF332.80 (25.7% above fair value)
  • GF Score™: 78/100 with 7 warning signs

No single metric tells the full story. See the XSWX:ROP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
78GF Score

Get the complete analysis for XSWX:ROP

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF332.80
Price
CHF264.67
GF Value